Portfolio Company Updates
Actinobac completes GLP toxicity studies of Leukothera.
Novopedics receives DOD award to advance its development of replacement meniscus.
Visikol expands image analysis as a service capability.
Recent Companies Launched
We are excited to support these companies as they begin to advance their important research toward commercialization.
FVCG Sells Interest in Durin
We have sold our equity interest in Durin Technologies, Inc. (Durin) to Breakthrough Diagnostics, Inc.
Durin was founded by Robert G. Nagele, PhD (pictured above), a professor and researcher at Rowan University School of Osteopathic Medicine, pursuing the development of blood tests to detect neurodegenerative diseases at very early stages.
FVCG, the original investor in Durin in 2010 supported Dr. Nagele's promising research.